FDA Grants Priority Review to Potential Sickle Cell Disease Treatment

Voxelotor (Global Blood Therapeutics) is being developed for patients with sickle cell disease.
— Read on www.specialtypharmacytimes.com/

This is great news for a disease with little options for treatment.

7 thoughts on “FDA Grants Priority Review to Potential Sickle Cell Disease Treatment”

Comments are closed.